Dicer-deficient cancers have poor prognoses, which is linked to the degradation of tumour-suppressing miRNA precursors by the Translin-Trax (Tn-Tx) ribonuclease. Inhibition of Tn-Tx potentially offers a new therapeutic intervention point. However, Tn-Tx functions in an array of biological processes, and here we consider how this complexity could influence therapeutic design strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.trecan.2020.02.014 | DOI Listing |
Publication Analysis
Top Keywords
translin-trax considerations
4
considerations oncological
4
oncological therapeutic
4
therapeutic targeting
4
targeting dicer-deficient
4
dicer-deficient cancers
4
cancers poor
4
poor prognoses
4
prognoses linked
4
linked degradation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!